Dr. Edgardo Santos explains that combining Tagrisso with chemotherapy or Leclaza plus Rybrevant may improve survival versus monotherapy alone. Treating patients with combination therapy approaches may ...

Modeyso's approval offers a new treatment for diffuse midline glioma with H3 K27M mutation, a previously untreatable condition beyond radiation. The drug is well-tolerated, with minimal side effects, ...

– Findings Support Continued Evaluation of Novel Strategies including Broadly Neutralizing HIV Antibodies, Vaccine Candidates, and TLR Agonists – A fourth pre-clinical study in a macaque model ...

Burkitt's lymphoma is a rare and aggressive blood cancer characterized by a translocation of the MYC gene. It occurs most often in children and young adults. In recent years, CAR-T cell therapy—often ...

NEW YORK, April 14, 2026 /PRNewswire/ -- The Lung Cancer Research Foundation (LCRF) announces the first recipients of its LCRF Team Science Award on Advancing Therapies Toward Curing EGFR Mutated Lung ...